AST to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic HBV infection

BACKGROUND: APRI (aspartate aminotransferase [AST] to platelet ratio index) is widely used to assess fibrosis and cirrhosis risk, especially in HCV-infected patients. Few studies have evaluated APRI and HBV-related hepatocellular carcinoma (HCC) risk. Prospective evidence is needed to assess whether...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Gastroenterol Hepatol
Auteurs principaux: Hann, Hie-Won, Wan, Shaogui, Lai, Yinzhi, Hann, Richard S., Myers, Ronald E., Patel, Fenil, Zhang, Kejin, Ye, Zhong, Wang, Chun, Yang, Hushan
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4418451/
https://ncbi.nlm.nih.gov/pubmed/24995497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgh.12664
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires